These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34004228)

  • 1. External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
    Sit D; Koh WX; Shokoohi A; Raycraft T; Vu M; Hamm J; Tran E; Berthelet E; Wu J; Olson R; Hamilton SN
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):468-478. PubMed ID: 34004228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.
    Besic N; Dremelj M; Pilko G
    Radiol Oncol; 2018 Sep; 52(4):453-460. PubMed ID: 30244234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of adjuvant external beam radiotherapy for papillary thyroid cancer based on competitive risk model and propensity score matching.
    Zhou J; Wu C; Fan S; Zhao M
    Sci Rep; 2023 Apr; 13(1):6925. PubMed ID: 37117278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
    Jin M; Megwalu UC; Noel JE
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: long-term outcomes.
    Calvo FA; Sole CV; Lozano MA; Gonzalez-Bayon L; Gonzalez-Sansegundo C; Alvarez A; Blanco J; Calín A; Lizarraga S; García-Sabrido JL
    Gynecol Oncol; 2013 Sep; 130(3):537-44. PubMed ID: 23707668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External-beam radiation therapy after surgical resection and intraoperative electron-beam radiation therapy for oligorecurrent gynecological cancer. Long-term outcome.
    Sole CV; Calvo FA; Lozano MA; Gonzalez-Bayon L; Gonzalez-Sansegundo C; Alvarez A; Lizarraga S; García-Sabrido JL
    Strahlenther Onkol; 2014 Feb; 190(2):171-80. PubMed ID: 24306064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base.
    Amini A; Jones BL; Jackson MW; Rusthoven CG; Maroni P; Kavanagh BD; Raben D
    Brachytherapy; 2016; 15(2):136-46. PubMed ID: 26825856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
    Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A; Kucuk O; Cimmino C; Szabo S; Rossi P; Baumann BC; Pattaras J; Hershatter B; Patel SA
    Brachytherapy; 2020; 19(5):557-566. PubMed ID: 32624405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of external beam radiation therapy in well-differentiated thyroid cancer.
    Hamilton SN; Tran E; Berthelet E; Wu J
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):905-910. PubMed ID: 28750593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of external irradiation for locally advanced papillary thyroid cancer.
    Kim TH; Yang DS; Jung KY; Kim CY; Choi MS
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1006-12. PubMed ID: 12605980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Medicine (Baltimore); 2020 Aug; 99(34):e21642. PubMed ID: 32846773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?
    Cavalcante LBCP; Treistman N; Gonzalez FMTT; Fernandes PIW; Alves Junior PAG; Andrade FA; Ferreira EN; Brito TF; Pane A; Corbo R; Erlich F; Bulzico DA; Vaisman F
    Head Neck; 2024 Jun; 46(6):1340-1350. PubMed ID: 38445804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.